Tesseract Medical Research Acquires PCS Tolling & Operations Business from Pulse Combustion Systems

July 26, 2023

Tesseract Medical Research has acquired the tolling & operations business of Pulse Combustion Systems (PCS), transferring PCS’s spray-drying contract manufacturing capabilities to Tesseract. The deal allows Tesseract to control tolling capacity for its nutraceutical and pharmaceutical formulations while enabling Pulse to focus on designing and manufacturing its proprietary spray-drying equipment.

Buyers
Tesseract Medical Research
Targets
PCS Tolling & Operations (Pulse Combustion Systems)
Sellers
Pulse Combustion Systems
Industry
Manufacturing
Location
Arizona, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.